Global MR Vaccine Market to 2028

company logo

company logo

MR vaccine market

MR vaccine market

MR vaccine market

Dublin, March 31, 2022 (GLOBE NEWSWIRE) — The “MR Vaccines Market, by Vaccine Brand, by Distribution Channel, and by Region: Size, Share, Outlook, and Opportunity Analysis, 2021 – 2028” Report has been added to ResearchAndMarkets.com offering.

Measles and rubella is a live virus vaccine that protects against infection with the measles and rubella viruses. It works by causing the body to produce its antiviral defenses (antibodies). Measles (also known as cough measles, hard measles, morbilli, red measles, rubella, and 10-day measles) is a highly contagious infectious disease.

Measles infection can cause serious complications, including pneumonia, ear infections, sinus infections, seizures (fits), brain damage, and death. Adults and children under 5 years of age are at increased risk of serious complications and mortality. When pregnant women get rubella (also known as German measles), it can lead to miscarriages, stillbirths, or birth defects in their unborn children.

market dynamics

The measles and rubella (MR) vaccine is a subcutaneous injection for active immunization against measles and rubella in young adults, adolescents, children, and infants at risk. Increased incidence of measles and rubella (MR), ongoing clinical trials to develop MR vaccines, increased awareness of immunization services, increased government initiatives to launch vaccination campaigns, and increased adoption of growth strategies inorganic, such as partnerships by key players operating in the MR vaccines market. with organizations such as WHO, UNICEF and GAVI Alliance being the main factors expected to drive the growth of the MR Vaccines market during the forecast period.

Key features of the study:

  • This report provides an in-depth analysis of the MR Vaccines market and provides the market size (US$ Mn. and number of doses in Mn.) and Compound Annual Growth Rate (CAGR%) for the forecast period (2021- 2028). ), considering 2020 as base year

  • It clarifies potential revenue opportunities in different segments and explains matrixes of attractive investment proposals for this market.

  • This study also provides key information on market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.

  • It profiles the key players in the MR Vaccines market based on the following parameters: company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, future strategies and plans.

  • Key companies covered as part of this study include PT Bio Farma, Bio-Manguinhos, BE Vaccines, Serum Institute of India and Crucell Switzerland AG.

  • The insights from this report would enable the marketers and management authorities of the companies to make informed decisions regarding their future product launches, rate upgrades, market expansion and marketing tactics.

  • The MR Vaccines market report is targeted at various stakeholders in this industry including investors, vendors, product manufacturers, distributors, new entrants, and financial analysts.

  • Stakeholders would have ease in decision making through various strategy matrices used in MR vaccine market analysis

Key Topics Covered:

1. Objectives and assumptions of the research

2. Market scope

  • Report Description

  • Market definition and scope

  • Executive Summary

  • Market fragment, by vaccine brand

  • Market fragment, by distribution channel

  • Market fragment, by region

  • Coherent Map of Opportunities (COM)

3. Market dynamics, regulations and trend analysis

4. MR vaccine market: impact of the coronavirus (Covid-19) pandemic

5. MR vaccine market, by vaccine brand, 2021 – 2028, (US$ Mn. and number of doses in Mn.)

  • Introduction

  • Market share analysis, 2021 and 2028 (%)

  • YoY Growth Analysis, 2018 – 2028

  • Segment Trends

  • MR vaccine

  • Introduction

  • Market Size and Forecast, and Growth YoY, 2017 – 2028, (US$ Mn. and No. of Doses in Mn.)

  • MRBEV (BE LTD.)

  • Introduction

  • Market Size and Forecast, and Growth YoY, 2017 – 2028, (US$ Mn. and No. of Doses in Mn.)

6. MR vaccine market, by distribution channel, 2021 – 2028, (US$ Mn. and No. of doses in Mn.)

  • Introduction

  • Market share analysis, 2021 and 2028 (%)

  • YoY Growth Analysis, 2018 – 2028

  • Segment Trends

  • Public

  • Introduction

  • Market Size and Forecast, and Growth YoY, 2017 – 2028, (US$ Mn. and No. of Doses in Mn.)

  • Private

  • Introduction

  • Market Size and Forecast, and Growth YoY, 2017 – 2028, (US$ Mn. and No. of Doses in Mn.)

7. MR vaccine market, by region, 2021 – 2028, (US$ Mn. and number of doses in Mn.)

8. Competitive landscape

  • Heat map analysis

  • Market share analysis

  • PT Biopharma

  • company overview

  • Product portfolio

  • Financial Summary

  • Key points

  • Marketing strategies

  • Bio-Manguinhos

  • company overview

  • Product portfolio

  • Financial Summary

  • Key points

  • Marketing strategies

  • Crucell Switzerland AG

  • company overview

  • Product portfolio

  • Financial Summary

  • Key points

  • Marketing strategies

  • Serum Institute of India

  • company overview

  • Product portfolio

  • Financial Summary

  • Key points

  • Marketing strategies

  • be vaccinated

  • company overview

  • Product portfolio

  • Financial Summary

  • Key points

  • Marketing strategies

  • Analyst Views

9. Section

For more information on this report, visit https://www.researchandmarkets.com/r/y6uxmm

Attachment

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

Leave a Reply

Your email address will not be published.